The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Womens Health Diagnostics Market Evolve From 2026 To 2030?
The womens health diagnostics market has observed significant growth in recent years. This market is set to expand from $36.88 billion in 2025 to $40.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. The expansion witnessed in previous periods is attributable to the increasing prevalence of women-specific diseases, the expansion of diagnostic infrastructure, a rising awareness of early screening benefits, the growth in laboratory testing services, and the adoption of imaging-based diagnostics.
The womens health diagnostics market size is expected to undergo significant expansion in the coming years. It is forecast to reach $59.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. This anticipated growth during the forecast period stems from factors such as increasing demand for personalized diagnostics, rising investments in precision testing technologies, the proliferation of home-based diagnostics, greater integration of AI analytics, and an intensified focus on preventive screening programs. Prominent trends throughout the forecast period include the increasing adoption of advanced imaging and testing technologies, the rising use of at-home diagnostic kits, growing integration of AI in diagnostic interpretation, the expansion of genetic and hormonal testing, and an enhanced emphasis on early disease detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10725&type=smp
What Major Drivers Are Influencing Demand In The Womens Health Diagnostics Market?
The escalating demand for personalized medicine is set to drive the expansion of the women’s health diagnostics market in the future. This medical approach involves custom treatments, diagnostics, or preventative measures informed by an individual’s unique genetic or protein makeup. It enables medical professionals to develop care strategies precisely suited to a woman’s distinct genetic, molecular, and clinical characteristics. Such strategies might include therapies targeting specific genetic indicators or biomarkers. As an illustration, the Personalized Medicine Coalition (PMC), a US-based nonprofit research entity, reported in February 2024 that the US Food and Drug Administration gave approval to 16 new personalized treatments for rare disease patients in 2023, marking a significant increase from 6 approvals in 2022; these 2023 approvals further included seven oncology therapies and three treatments addressing other diverse ailments. Consequently, the heightened demand for personalized medicine is acting as a catalyst for the expansion of the women’s health diagnostics market.
Which Segment Areas Are Covered In The Womens Health Diagnostics Market Analysis?
The womens health diagnostics market covered in this report is segmented –
1) By Type: Accessories And Consumables, Diagnostic Tests, Diagnostic Devices
2) By Application: Osteoporosis Testing, Ovarian Cancer Testing (OVC), Cervical Cancer Testing, Breast Cancer Testing, Pregnancy And Fertility Testing, Prenatal Genetic Screening And Carrier Testing, Infectious Disease Testing, Sexually Transmitted Diseases (STD) Testing, Ultrasound Tests
3) By End User: Hospitals And Clinics, Diagnostic And Imaging Centers, Homecare, Other End Users
Subsegments:
1) By Accessories And Consumables: Test Kits, Sample Collection Devices, Reagents, Control Materials
2) By Diagnostic Tests: Blood Tests, Imaging Tests, Genetic Tests, Hormonal Tests
3) By Diagnostic Devices: Imaging Devices, Invasive Diagnostic Devices, Non-Invasive Diagnostic Devices, Monitoring Devices
Which Market Trends Are Creating New Opportunities In The Womens Health Diagnostics Market?
Leading companies in the women’s health diagnostics market are concentrating on product innovations, including premium ultrasound systems, to maintain their market position. A premium ultrasound system is defined as a sophisticated and advanced medical imaging device crafted to capture detailed, high-quality images of internal human body structures. This type of system is a component of Samsung’s HERA platform, specifically tailored for obstetrics and gynecology. For example, in February 2023, Samsung’s digital radiography and ultrasound business, a US-based entity, launched the HERA W10 Elite, an advanced women’s health ultrasound system. It is equipped with a suite of artificial intelligence (AI) tools and clinical applications, marking a significant enhancement in the diagnostic experience for women’s health. The HERA W10 Elite features advanced capabilities such as MV-Flow for displaying blood flow intensity, BiometryAssist for convenient fetal growth parameter measurement, and precise analytic functions to aid clinicians in diagnosis.
Which Global Companies Are Actively Competing In The Womens Health Diagnostics Market?
Major companies operating in the womens health diagnostics market are Becton Dickinson And Company, F. Hoffmann-La Roche AG, General Electric Company, Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Abbott Laboratories, BioMérieux SA, Hologic Inc., PerkinElmer Inc., Alere Inc., Carestream Health Inc., Procter & Gamble Co., Trinity Biotech plc, Medgyn Products Inc., URIT Medical Electronic Co. Ltd, Sonic Healthcare Limited, Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Genomic Health Inc., Invitae Corporation, Natera Inc., QIAGEN N.V., Opko Health Inc., Sysmex Corporation, Exact Sciences Corporation, Foundation Medicine Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc.
Read the full womens health diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/womens-health-diagnostics-global-market-report
Which Region Shows The Strongest Potential For Future Growth In The Womens Health Diagnostics Market?
North America was the largest region in the women’s health diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global women’s health diagnostics market report during the forecast period. The regions covered in the womens health diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Womens Health Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10725&type=smp
Browse Through More Reports Similar to the Global Womens Health Diagnostics Market 2026, By The Business Research Company
Womens Health Global Market Report
https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report
Clinical Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Womens Health Devices Global Market Report
https://www.thebusinessresearchcompany.com/report/womens-health-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model